Don't Miss Out on Our New Products!
Biocare Medical has been busy ensuring you supply the highest quality reagents for your laboratory on every automated platform. Have you seen the latest releases from us, such as CD137, PSAP and LMO2?
We have increased our menu of antibodies for the Leica Bond* with our Q Series reagents and the Roche BenchMark Ultra with our UltraLine* products. Our research and development teams specifically built and optimized these antibodies to work effortlessly on your automated IHC platforms.
CD137 Antibody
![Tonsil stained with CD137 [BLR051F] antibody](https://biocare.net/wp-content/uploads/3264.jpg)
CD137 (4-1BB), or tumor necrosis factor receptor superfamily member 9 (TNFRSF9), is a promising target for enhancing antitumor immune responses without the autoimmune side effects associated with immunotherapy approaches.1 CD137 signaling plays a significant role in multiple cells and regulates the activity of many immune cells.
PSAP Antibody
![Prostate stained with PSAP [rACCP/1338] antibody](https://biocare.net/wp-content/uploads/3263.jpg)
Prostate-specific acid phosphatase (PSAP) is an enzyme produced in prostate epithelial cells. PSAP expression levels proportionally increase with prostate cancer progression.1 PSAP IHC staining is often used in conjunction with prostate specific antigen (PSA) staining to help distinguish poorly differentiated carcinomas. PSAP is commonly used to help differentiate prostate adenocarcinoma and urothelial carcinoma which may appear microscopically similar; prostate adenocarcinoma often stains with PSA and/or PSAP.2
LMO2 Antibody
![Tonsil stained with LMO2 [SP51] antibody.](https://biocare.net/wp-content/uploads/3262.jpg)
LMO2 is part of the LIM-only family of proteins which has four members (LMO1-4) that are implicated in a variety of cancers. LMO2 is linked to diffuse large B cell lymphoma (DLBCL) and prostate cancer.1 LMO2 protein is a nuclear marker, expressed in normal germinal-center (GC) B cells and in a subset of GC-derived B-cell lymphomas.
platform optimizations
Biocare Q Series is a comprehensive antibody portfolio built specifically for your Leica Bond IHC Instrument. The Q Series of antibodies is conveniently ready-to-use, with each vial containing 7mL of antibody. If you’re looking for an extensive menu of novel antibodies at the highest level of quality for the Leica Bond IHC instrument, the Q Series is the perfect solution.
Biocare UltraLine is a comprehensive antibody portfolio built specifically for your Roche/Ventana BenchMark Instrument. This powerful UltraLine of antibodies is ready-to-use with an extensive menu of novel antibodies at the highest level of quality. The UltraLine is the perfect solution of antibodies for your Roche BenchMark Ultra.
*UltraLine antibodies are developed solely by Biocare Medical and do not imply approval or endorsement of Biocare’s antibodies by Roche® or VENTANA®. Biocare and Roche/Ventana are not affiliated, associated or related in any way. Roche®, Ventana®, Benchmark® XT, and Benchmark® Ultra are registered trademarks of Roche. *Q Series™ antibodies are developed solely by Biocare Medical LLC and do not imply approval or endorsement of Biocare antibodies by Leica Biosystems. Biocare and Leica Biosystems are not affiliated, associated or related in any way. Leica, Leica Biosystems, BOND-MAX and BOND-III are trademarks of Leica Biosystems.